Lipidem (Omega-3-Acid Triglycerides, Soya-Bean Oil Refined, Triglycerides, Medium Chain)

Omega-3-Acid Triglycerides are hydrolyzed by lipoprotein lipase after infusion, releasing free fatty acids that serve as an immediate energy substrate. The fatty acids are also incorporated into cell‑membrane phospholipids, supplying polyunsaturated fatty acids needed for membrane integrity, eicosanoid synthesis, and other cellular functions.

The dose of Lipidem is individualized by the prescribing clinician based on the patient’s caloric requirements, body weight, underlying condition, and laboratory parameters such as triglyceride and liver‑function tests. No fixed regimen is provided; the healthcare professional calculates the appropriate volume and infusion rate for each case.

Safety data for Lipidem during pregnancy and lactation are limited. Because it contains high levels of omega‑3 fatty acids, it may be used when the potential benefit to the mother outweighs any theoretical risk to the fetus or infant. The decision should be made by the treating physician in consultation with obstetric specialists.

To place an order, submit an enquiry on the Lipidem product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain handling where required) and any necessary import documentation.

Lipidem is distinguished by its blend of refined soybean oil and medium‑chain triglycerides rich in omega‑3 fatty acids, offering a balanced omega‑6 to omega‑3 ratio. Compared with traditional soybean‑only emulsions, it may provide a lower risk of inflammation and a more favorable lipid profile, while delivering comparable caloric density for parenteral nutrition.

Lipidem must be stored refrigerated between 2 °C and 8 °C. It should be kept in its original container, protected from light, and must not be frozen or shaken vigorously. Before use, allow the emulsion to reach room temperature if required by the administration protocol, and inspect for any signs of separation or discoloration.

Lipidem is administered intravenously as a sterile lipid emulsion. It is typically infused through a dedicated lumen or a compatible IV line using an infusion pump to control the rate. The infusion rate is set according to the prescribed caloric goal and patient tolerance, and the line is monitored for signs of phlebitis or infiltration.

Serious adverse events include fat overload syndrome, which can cause hepatic dysfunction, and severe hypersensitivity reactions such as anaphylactoid responses. Additionally, excessive lipid administration may lead to hypertriglyceridemia and coagulopathy. Prompt recognition of these signs and immediate medical intervention are essential.

Lipidem is contraindicated in patients with known hypersensitivity to any component of the emulsion, those with severe hyperlipidaemia, uncontrolled pancreatitis, or a documented fat overload syndrome. Caution is also advised for neonates, patients with severe liver disease, or individuals receiving concurrent high‑dose lipid‑containing therapies.